221800 — U2Bio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapFalling Star

Annual balance sheet for U2Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,512	16,485	36,921	36,792	33,991
Net Total Accounts Receivable
Net Total Receivables	16,708	21,759	10,183	7,391	7,477
Total Inventory
Prepaid Expenses
Total Current Assets	21,580	38,869	47,873	45,172	42,332
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,119	1,177	1,871	1,549	1,186
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	22,997	41,334	51,028	49,199	44,983
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,437	17,734	14,634	8,003	6,614
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	17,056	19,811	17,184	11,208	10,555
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	5,942	21,524	33,844	37,991	34,427
Total Liabilities & Shareholders' Equity	22,997	41,334	51,028	49,199	44,983
Total Common Shares Outstanding